Bristol Myers Squibb (BMY) Receivables - Other (2009 - 2026)
Bristol Myers Squibb (BMY) recorded Receivables - Other of $85 million in Q3 2026, down 95.3% from $1.8 billion a year earlier and down 21.3% from the prior quarter.
Bristol Myers Squibb (BMY) Receivables - Other (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb reported Receivables - Other of $1.82 billion, up 5.0% from FY2024.
- Annual Receivables - Other has a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- Across earlier years, Receivables - Other came in at $1.74 billion in FY2024 (-14.9%), $2.04 billion in FY2023 (+17.5%), $1.74 billion in FY2022 (+24.8%) and $1.39 billion in FY2021 (+8.4%).
- The Q3 2026 figure is the lowest quarterly Receivables - Other in data going back to Q4 2009.
- On a year-over-year basis, Receivables - Other has declined for four consecutive quarters, with an average decline of 31.3% over the last eight quarters.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 62.4% in Q1 2023, against a decline of 95.3% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $108 million (Q2 2026), $1.42 billion (Q1 2026) and $192 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 85.00 Mn |
| Jun 30, 2026 | 108.00 Mn |
| Mar 31, 2026 | 1.42 Bn |
| Dec 31, 2025 | 192.00 Mn |
| Sep 30, 2025 | 1.80 Bn |
| Jun 30, 2025 | 1.70 Bn |
| Mar 31, 2025 | 1.74 Bn |
| Dec 31, 2024 | 385.00 Mn |
| Sep 30, 2024 | 1.71 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | 1.62 Bn |
| Dec 31, 2023 | 416.00 Mn |
| Sep 30, 2023 | 1.90 Bn |
| Jun 30, 2023 | 1.99 Bn |
| Mar 31, 2023 | 2.20 Bn |
| Dec 31, 2022 | 504.00 Mn |
| Sep 30, 2022 | 1.59 Bn |
| Jun 30, 2022 | 1.47 Bn |
| Mar 31, 2022 | 1.36 Bn |
| Dec 31, 2021 | 361.00 Mn |
Bristol Myers Squibb Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();